Ultrasound Imaging of Kidney Stones and Lithotripsy
Launched by UNIVERSITY OF WASHINGTON · Aug 8, 2014
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to use ultrasound images to help find and measure kidney stones more accurately. Kidney stones are hard deposits that can form in your kidneys and cause pain. The researchers want to see if new software can make it easier to detect these stones compared to traditional methods.
To participate in this study, you need to be at least 21 years old and have kidney stones that can be seen on an x-ray. You must also have had a CT scan within the last 90 days and be able to give your consent to participate. Unfortunately, people who can't give consent, are under 21, have stones not visible on x-ray, or have certain health issues may not be eligible. If you join the trial, you’ll help researchers understand if this new ultrasound technology can improve how kidney stones are diagnosed, potentially leading to better care for patients like you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with kidney stones that are visible on x-ray (i.e., calcium stones)
- • Current CT scan within the 90-day pre-operative period
- • Able to give informed consent
- • Age 21 years or older
- Exclusion Criteria:
- • Inability to give informed consent
- • Age less than 21 years
- • Stones not visible on x-ray
- • Patients with systemic disease or renal anatomical disorders (RTA, primary hyperparathyroidism, sarcoidosis, enteric hyperoxaluria, medullary sponge kidney)
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Michael Bailey
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials